Результаты многоцентрового сравнительного исследования эффективности и безопасности терапии препаратами биматопроста 0,03% и травопроста 0,004%

PURPOSE: To evaluate and compare the intraocular pressure changes in patients with initial and advanced stages of open-angle glaucoma (POAG) when using the study drug bimatoprost 0.03% and the comparison drug travoprost 0.004%, as well as to assess the effect of these drugs on the ocular surface. METHODS: The study involved 81 patients (137 eyes), 48 women and 23 men, with a mean age of 63 years. Patients of the first group (36 patients, 69 eyes) received 0.03% bimatoprost for 3 months. Patients of the second group (35 patients, 68 eyes) received 0.004% travoprost for 3 months. RESULTS: According to tonometry data, a hypotensive effect was observed in both groups. Regardless of the method of tonometry, intraocular pressure was lower in the group of patients receiving 0.03% bimatoprost (p<0.001). In both groups, the state of the anterior segment of the eye was affected in the form of increased hyperemia and an increase in spot staining of the cornea and conjunctiva with fluorescein according to the Oxford scale. However, there was no significant differences between the action of 0.03% bimatoprost and 0.004% travoprost drugs. CONCLUSION: The hypotensive effect of bimatoprost 0.03% was better than travoprost 0.004%. Both drugs had an effect on the ocular surface. The incidence of adverse events in the group of patients treated with bimatoprost did not exceed similar results for travoprost.